EpiAxis Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast Cancer (NCT03505528) | EpiAxis Therapeutics | 2017-08-17 |
Track EpiAxis Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.